JB Chemicals & Pharmaceuticals Limited — Board Meeting, 14-05-2025: Outcome of Board Meeting

J.B. Chemicals & Pharmaceuticals has announced a board meeting to approve the financial results for the quarter and half-year. Consolidated revenue jumped to ₹3,917 Cr from ₹3,484 Cr YoY, with profit before tax at ₹887 Cr and net profit rising to ₹660 Cr from ₹552 Cr. Operational efficiency improved on controlled material costs and stable employee expenses. Strong cash flow from operations stood at ₹902 Cr. A final dividend of ₹7 per share has been proposed. The company is pushing growth through franchise expansion and increased R&D investments.